Streptococcus faecium-derived antibacterial substance antagonistic to Bifidobacteria

Area of Science:

• Microbiology
• Biochemistry

Background:

• Human gut microbiota plays a crucial role in health.
• Dysbiosis, an imbalance in gut bacteria, is linked to various diseases.
• Identifying specific bacterial interactions is key to understanding gut health.

Purpose of the Study:

• To isolate and characterize an antibacterial substance from an antagonistic Streptococcus faecium strain.
• To investigate the properties and potential therapeutic applications of this substance.

Main Methods:

• Isolation of Streptococcus faecium from human feces.
• Culturing and purification of the antibacterial substance using ammonium sulfate precipitation, gel filtration, and ion-exchange chromatography.
• Assaying antibacterial activity against Bifidobacterium longum.
• Characterizing substance stability through enzymatic and chemical treatments, and heat exposure.
• Estimating molecular weight via gel filtration.

Main Results:

• An antagonistic Streptococcus faecium strain was identified, inhibiting bifidobacteria growth.
• An antibacterial substance was produced, partially purified, and its activity against Bifidobacterium longum confirmed.
• The substance demonstrated sensitivity to proteolytic enzymes and alpha-amylase.
• It was resistant to urea, reducing agents, organic solvents, and lysozyme.
• The substance was heat-stable up to 100°C for 60 minutes and had an estimated molecular weight of 50,000 Da.

Conclusions:

• Streptococcus faecium produces a heat-stable antibacterial substance targeting Bifidobacterium longum.
• The substance's biochemical properties suggest a protein or glycoprotein nature.
• This finding has implications for understanding microbial antagonism and developing probiotics or therapeutics for gut health.